- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Progressive Metastatic Malignancies in Hong Kong
Total 212 results
-
The University of Hong KongResearch Grants Council, Hong KongRecruitingFear of Cancer Progression | Metacognition-based Intervention | Supportive-expressive Based Intervention | Psychooncology | Advanced or Metastatic CancerHong Kong
-
The University of Hong KongRecruitingPeritoneal MetastasesHong Kong
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of Technology; Menicon Co., Ltd.Completed
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of Technology; Menicon Co., Ltd.Completed
-
The Hong Kong Polytechnic UniversityMenicon Co., Ltd.Active, not recruitingMyopic ProgressionHong Kong
-
The Hong Kong Polytechnic UniversityMenicon Co., Ltd.Active, not recruitingMyopic ProgressionHong Kong
-
The University of Hong KongChinese University of Hong KongCompletedProgression From Impaired Fasting Glucose to Diabetes MellitusHong Kong
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
Vincent MokRecruitingParkinson Disease | Neurodegenerative Diseases | Multiple System Atrophy | Progressive Supranuclear PalsyHong Kong
-
The University of Hong KongUnknownMetastatic Colorectal Cancer | Circulating Tumor CellHong Kong
-
The University of Hong KongRecruitingCancer | Graft Vs Host Disease | Haematological MalignancyHong Kong
-
Chinese University of Hong KongCompleted
-
The University of Hong KongUnknown
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongActive, not recruiting
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongRecruitingParkinson Disease | Aging | Dementia Alzheimers | Depression in Old Age | Dementia FrontotemporalHong Kong
-
Hong Kong Children's HospitalThe University of Hong KongRecruitingCarcinoma | Cancer | Solid Tumor | MalignancyHong Kong
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongRecruitingGastrointestinal Cancer | Circulating Tumor CellHong Kong
-
The University of Hong KongMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...CompletedNasopharyngeal Carcinoma | Metastatic Cancer | Recurrent Carcinoma | Non-keratinizing CarinomaHong Kong
-
The University of Hong KongUnknownAdvanced Hepatocellular Carcinoma | Metastatic Hepatocellular CarcinomaChina
-
The University of Hong KongCompletedVascular Diseases | Secondary Hyperparathyroidism | Kidney FailureHong Kong
-
The University of Hong KongAbbVieUnknownSecondary Hyperparathyroidism | Endstage Renal DiseaseHong Kong
-
Chinese University of Hong KongDepartment of Electronic and computer engineering, HKUST; Department of clinical... and other collaboratorsRecruitingBreast CancerHong Kong
-
Chinese University of Hong KongActive, not recruitingChronic Hepatitis BHong Kong
-
Chinese University of Hong KongCompletedDyspepsia | Gastroesophageal Reflux | Peptic Ulcer Disease | Pancreatobiliary Disease | Ugi MalignanciesHong Kong
-
Medtronic - MITGCompletedCancer, Lung | Cancer, Metastatic to LungHong Kong, United Kingdom
-
The University of Hong KongRecruitingHepatocellular Carcinoma | Circulating Tumor CellChina
-
AmgenActive, not recruitingAdvanced/Metastatic Solid Tumors With KRAS p.G12C MutationTaiwan, Hong Kong
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedMetastatic Cancer | Liver CancerUnited States, China
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
Astellas Pharma IncActive, not recruitingProgressive Metastatic Prostate CancerChina, Hong Kong, Korea, Republic of, Taiwan
-
Treadwell Therapeutics, IncTIO Discovery EngineRecruitingAdvanced Solid MalignanciesUnited States, Hong Kong, Canada
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
GlaxoSmithKlineCompletedNeoplasms, MetastasisKorea, Republic of, Hong Kong, Philippines, Singapore
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited States, Korea, Republic of, Taiwan, France, Hong Kong, Belgium, Spain
-
Hoffmann-La RocheCompletedCarcinoma, Hepatocellular | Liver Metastases | Biliary Tract Cancer | Secondary Liver CancerKorea, Republic of, Denmark, Spain, Taiwan, United States, Hong Kong
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.CompletedSecondary HyperparathyroidismChina, Hong Kong, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)TerminatedParaganglioma | Metastatic Adrenal Gland Pheochromocytoma | Recurrent Adrenal Gland Pheochromocytoma | Extra-Adrenal ParagangliomaUnited States, Singapore, Hong Kong
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingEsophageal Neoplasms | Lymph Node MetastasesNetherlands, United States, Italy, Spain, Sweden, Brazil, Canada, China, Finland, Germany, Greece, Hong Kong, India, Japan
-
National Cancer Center, KoreaTerminatedBreast Cancer | Metastatic DiseaseKorea, Republic of
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
PfizerCompletedBreast Neoplasms | Neoplasm MetastasisUnited States, Ukraine, Russian Federation, Hong Kong, France, Australia, Poland, Malta
-
SanofiRegeneron PharmaceuticalsCompletedColorectal Cancer MetastaticTaiwan, China, Hong Kong, Japan, Singapore
-
Regeneron PharmaceuticalsRecruitingFibrodysplasia Ossificans ProgressivaJapan, United States, Korea, Republic of, Spain, France, Australia, United Kingdom, China, Poland, Malaysia, Italy, Finland, Hong Kong, South Africa, Chile, Brazil, Netherlands, Colombia
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia (ALL) | Chronic Myelogenous Leukemia (CML) | Metastatic Gastrointestinal Stromal Tumors (GIST) | Receptor Tyrosine Kinase (KIT) Mutated MelanomaItaly, United Kingdom, Canada, Singapore, Netherlands, France, Korea, Republic of, United States, Slovakia, Hungary, Russian Federation, Hong Kong, Spain, Israel, Sweden, Austria
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia